Back to LYEL
GOLDMAN SACHS GROUP INC → LYEL
GOLDMAN SACHS GROUP INC LYEL Position History
Lyell Immunopharma, Inc. • Healthcare
Quarters held
6
Latest value
$116K
Q3 2026
Peak value
$3M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $3M |
| Q4 2025 | $3M |
| Q1 2026 | $2.3M |
| Q2 2026 | $1.2M |
| Q3 2026 | $947K |
| Q3 2026 | $116K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $116K | 11.9K | — | — |
| Q3 2026 | $947K | 96.7K | — | — |
| Q2 2026 | $1.2M | 86.8K | — | — |
| Q1 2026 | $2.3M | 114.5K | — | — |
| Q4 2025 | $3M | 96.7K | — | — |
| Q4 2025 | $3M | 96.7K | — | — |
Other funds holding LYEL
$46.6M
$30.3M
$23.2M